SteadyMed Ltd.
NASDAQTotal Valuation
SteadyMed Ltd. carries a market capitalization of - -, placing it among publicly traded companies globally. Its enterprise value stands at 98.46M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | - - |
| Enterprise Value | 98.46M |
Share Statistics
SteadyMed Ltd. currently has 26.74M shares outstanding.
| Shares Outstanding | 26.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 278.11, and the price-to-book ratio stands at -0.90.
| PE Ratio | N/A |
| PS Ratio | 278.11 |
| PB Ratio | -0.90 |
| P/TBV Ratio | 27.70 |
| P/FCF Ratio | -6.61 |
| P/OCF Ratio | -5.83 |
Enterprise Valuation
| EV / Sales | 228.97 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
SteadyMed Ltd. maintains a current ratio of 4.80, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.80 |
| Quick Ratio | 4.80 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -3.25 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -44.07 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -140,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
SteadyMed Ltd.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 4.67, while the 200-day moving average is 3.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 4.67 |
| 200-Day Moving Average | 3.89 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, SteadyMed Ltd. generated 430,000.00 in revenue and converted that into -16.92M in net income, yielding earnings per share of -0.62. EBITDA reached -22.46M, while operating income came in at -23.32M.
| Revenue | 430,000.00 |
| Gross Profit | N/A |
| Operating Income | -23.32M |
| Pretax Income | -17.06M |
| Net Income | -16.92M |
| EBITDA | -22.46M |
| EBIT | -23.32M |
| Earnings Per Share (EPS) | -0.62 |
Balance Sheet
Total book value stands at -132.73M, with working capital of 16.99M providing operational flexibility.
| Cash & Cash Equivalents | 21.13M |
| Total Debt | N/A |
| Net Debt | -21.13M |
| Equity (Book Value) | -132.73M |
| Book Value Per Share | -4.99 |
| Working Capital | 16.99M |
Cash Flow
SteadyMed Ltd. produced -20.53M in operating cash flow over the past twelve months. After subtracting -2.04M in capital expenditures, free cash flow totaled -22.57M - equivalent to -0.85 per share.
| Operating Cash Flow | -20.53M |
| Capital Expenditures | -2.04M |
| Free Cash Flow | -22.57M |
| FCF Per Share | -0.85 |
Margins
SteadyMed Ltd. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -5,422.33 and net profit margin of -3,935.81 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -5,422.33 |
| Pretax Margin | -3,968.37 |
| Profit Margin | -3,935.81 |
| EBITDA Margin | -5,223.72 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.04 |
| FCF Yield | -15.14 |
Scores
SteadyMed Ltd. posts an Altman Z-Score of -5.65, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -5.65 |